Renal phosphate wasting disorders: clinical features and pathogenesis

Bell, 2001, Osteomalacia and rickets, 615

Whyte, 1996, X-linked hypophosphatemia, J Clin Endocrinol Metab, 81, 4075, 10.1210/jc.81.11.4075

Winters, 1991, A genetic study of familial hypophosphatemia and vitamin d resistant rickets with a review of the literature, Medicine, 70, 215, 10.1097/00005792-199105000-00006

Polisson, 1985, Calcification of entheses associated with x-linked hypophosphatemic osteomalacia, N Engl J Med, 313, 1, 10.1056/NEJM198507043130101

Econs, 1991, X-linked hypophosphatemic rickets without “rickets.”, Skeletal Radiol, 20, 109, 10.1007/BF00193821

Hardy, 1989, X-linked hypophosphatemia in adults, Radiology, 171, 403, 10.1148/radiology.171.2.2539609

Econs, 1997, Autosomal dominant hypophosphatemic rickets/osteomalacia, J Clin Endocrinol Metab, 82, 674, 10.1210/jc.82.2.674

Scriver, 1977, Hypophosphatemic nonrachitic bone disease, Am J Med Genet, 1, 101, 10.1002/ajmg.1320010111

2000, Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. The ADHR consortium, Nat Genet, 26, 345, 10.1038/81664

Tieder, 1985, Hereditary hypophosphatemic rickets with hypercalciuria, N Engl J Med, 312, 611, 10.1056/NEJM198503073121003

Tieder, 1987, “Idiopathic” hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect, N Engl J Med, 316, 125, 10.1056/NEJM198701153160302

Ryan, 1984, Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases, Am J Med, 77, 501, 10.1016/0002-9343(84)90112-8

Drezner, 1999, Tumor-induced osteomalacia, 331

Eicher, 1976, Hypophosphatemia, Proc Natl Acad Sci U S A, 73, 4667, 10.1073/pnas.73.12.4667

Lobaugh, 1983, Abnormal regulation of renal 25-hydroxyvitamin d-1 alpha-hydroxylase activity in the x-linked hypophosphatemic mouse, J Clin Invest, 71, 400, 10.1172/JCI110783

Ecarot-Charrier, 1988, Defective bone formation by transplanted hyp mouse bone cells into normal mice, Endocrinology, 123, 768, 10.1210/endo-123-2-768

Meyer, 1989, Parabiosis suggests a humoral factor is involved in x-linked hypophosphatemia in mice, J Bone Miner Res, 4, 493, 10.1002/jbmr.5650040407

Nesbitt, 1992, Crosstransplantation of kidneys in normal and hyp mice. Evidence that the hyp mouse phenotype is unrelated to an intrinsic renal defect, J Clin Invest, 89, 1453, 10.1172/JCI115735

Econs, 1994, Tumor-induced osteomalacia—unveiling a new hormone, N Engl J Med, 330, 1679, 10.1056/NEJM199406093302310

1995, A gene (PEX) with homologies to endopeptidases is mutated in patients with x-linked hypophosphatemic rickets. The HYP consortium, Nat Genet, 11, 130, 10.1038/ng1095-130

Beck, 1997, Pex/pex tissue distribution and evidence for a deletion in the 3′ region of the pex gene in x-linked hypophosphatemic mice, J Clin Invest, 99, 1200, 10.1172/JCI119276

Strom, 1997, Pex gene deletions in gy and hyp mice provide mouse models for x-linked hypophosphatemia, Hum Mol Genet, 6, 165, 10.1093/hmg/6.2.165

Francis, 1997, Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets, Genome Res, 7, 573, 10.1101/gr.7.6.573

Xu, 1994, Ece-1, Cell, 78, 473, 10.1016/0092-8674(94)90425-1

Welches, 1993, A comparison of the properties and enzymatic activities of three angiotensin processing enzymes, Life Sci, 52, 1461, 10.1016/0024-3205(93)90108-F

Ruchon, 1998, Pex mRNA is localized in developing mouse osteoblasts and odontoblasts, J Histochem Cytochem, 46, 459, 10.1177/002215549804600405

Grieff, 1997, Expression and cloning of the human x-linked hypophosphatemia gene cDNA, Biochem Biophys Res Commun, 231, 635, 10.1006/bbrc.1997.6153

Lajeunesse, 1996, Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the hyp mouse, Kidney Int, 50, 1531, 10.1038/ki.1996.468

Ecarot, 1992, Defective bone formation by hyp mouse bone cells transplanted into normal mice, J Bone Miner Res, 7, 215, 10.1002/jbmr.5650070213

Ecarot, 1994, Phosphate transport by osteoblasts from x-linked hypophosphatemic mice, Am J Physiol, 266, E33

Ecarot, 1995, Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice, J Bone Miner Res, 10, 424, 10.1002/jbmr.5650100313

Xiao, 1998, Intrinsic mineralization defect in Hyp mouse osteoblasts, Am J Physiol, 275, E700

Bai, 2002, Partial rescue of the hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the x chromosome) expression, Mol Endocrinol, 16, 2913, 10.1210/me.2002-0113

Liu, 2002, Overexpression of PHEX in osteoblasts fails to rescue the Hyp mouse phenotype, J Biol Chem, 277, 3686, 10.1074/jbc.M107707200

DiMeglio, 2000, Disorders of phosphate metabolism, Endocrinol Metab Clin North Am, 29, 591, 10.1016/S0889-8529(05)70152-3

Econs, 1997, Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13, J Clin Invest, 100, 2653, 10.1172/JCI119809

Kumar, 2000, Tumor-induced osteomalacia and the regulation of phosphate homeostasis, Bone, 27, 333, 10.1016/S8756-3282(00)00334-3

White, 2001, The autosomal dominant hypophosphatemic rickets (adhr) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting, J Clin Endocrinol Metab, 86, 497, 10.1210/jc.86.2.497

Shimada, 2001, Cloning and characterization of fgf23 as a causative factor of tumor-induced osteomalacia, Proc Natl Acad Sci U S A, 98, 6500, 10.1073/pnas.101545198

Yamashita, 2000, Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain, Biochem Biophys Res Commun, 277, 494, 10.1006/bbrc.2000.3696

Shimada, 2002, FGF-23 is a novel regulator of mineral homeostasis with unique properties controlling vitamin D metabolism and phosphate reabsorption, J Bone Miner Res, 17, S168

Yamazaki, 2002, Increased circulatory level of biologically active full-length fgf-23 in patients with hypophosphatemic rickets/osteomalacia, J Clin Endocrinol Metab, 87, 4957, 10.1210/jc.2002-021105

Jonsson, 2002, FGF-23 is a circulating factor that is elevated in oncogenic osteomalacia and x-linked hypophosphatemic rickets, J Bone Miner Res, 17, 158

Jan De Beur, 2002, Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism, J Bone Miner Res, 17, 1102, 10.1359/jbmr.2002.17.6.1102

Rowe, 2000, MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia, Genomics, 67, 54, 10.1006/geno.2000.6235

Gowen, 2003, Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass, J Biol Chem, 278, 1998, 10.1074/jbc.M203250200

Vassiliadis, 2001, Frizzled related protein 4 expression is elevated in tumors associated with oncogenic osteomalacia and inhibits phosphate transport in vitro, J Bone Miner Res, 16, S225

Berndt, 2002, Effect of the acute infusion of frizzled related protein 4 (FRP-4), a protein highly expressed in tumors associated with osteomalacia, on phosphate excretion in vivo, J Bone Miner Res, 17, S158

White, 2001, Autosomal-dominant hypophosphatemic rickets (adhr) mutations stabilize fgf-23, Kidney Int, 60, 2079, 10.1046/j.1523-1755.2001.00064.x

Bowe, 2001, Fgf-23 inhibits renal tubular phosphate transport and is a phex substrate, Biochem Biophys Res Commun, 284, 977, 10.1006/bbrc.2001.5084

Guo, 2001, Analysis of recombinant phex, Am J Physiol, 281, E837

Jonsson, 2003, Fibroblast growth factor 23 in oncogenic osteomalacia and x-linked hypophosphatemia, N Engl J Med, 348, 1656, 10.1056/NEJMoa020881

Rizzoli, 1977, Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply, J Clin Invest, 60, 639, 10.1172/JCI108815

Lee, 1986, Intestinal phosphate absorption, Am J Physiol, 250, G369

Murer, 1996, Molecular mechanisms of renal apical na/phosphate cotransport, Annu Rev Physiol, 58, 607, 10.1146/annurev.ph.58.030196.003135

Kempson, 1995, Parathyroid hormone action on phosphate transporter mrna and protein in rat renal proximal tubules, Am J Physiol, 268, F784

Kronenberg, 2002, Npt2a—the key to phosphate homeostasis, N Engl J Med, 347, 10.1056/NEJMe020098

Tenenhouse, 1996, Renal Na(+)-phosphate cotransporter gene expression in X-linked Hyp and Gy mice, Kidney Int, 49, 1027, 10.1038/ki.1996.149

Prie, 2002, Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter, N Engl J Med, 347, 983, 10.1056/NEJMoa020028

Tenenhouse, 2001, Mendelian hypophosphatemias, 5039

Taylor, 1995, Nephrocalcinosis in x-linked hypophosphatemia, Pediatr Nephrol, 9, 173, 10.1007/BF00860736

Balsan, 1990, Linear growth in patients with hypophosphatemic vitamin d-resistant rickets, J Pediatr, 116, 365, 10.1016/S0022-3476(05)82822-7

Blydt-Hansen, 1999, Phex expression in parathyroid gland and parathyroid hormone dysregulation in x-linked hypophosphatemia, Pediatr Nephrol, 13, 607, 10.1007/s004670050669

Goodyer, 1987, Nephrocalcinosis and its relationship to treatment of hereditary rickets, J Pediatr, 111, 700, 10.1016/S0022-3476(87)80245-7

Verge, 1991, Effects of therapy in x-linked hypophosphatemic rickets, N Engl J Med, 325, 1843, 10.1056/NEJM199112263252604

Reid, 1989, X-linked hypophosphatemia, Medicine (Baltimore), 68, 336, 10.1097/00005792-198911000-00002

Firth, 1985, Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases, Am J Med, 78, 669, 10.1016/0002-9343(85)90411-5

Drezner, 1980, Evaluation of a role for 1,25-dihydroxyvitamin d3 in the pathogenesis and treatment of x-linked hypophosphatemic rickets and osteomalacia, J Clin Invest, 66, 1020, 10.1172/JCI109930

Rasmussen, 1981, Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin d3, J Pediatr, 99, 16, 10.1016/S0022-3476(81)80951-1

Glorieux, 1980, Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin d-resistant rickets, N Engl J Med, 303, 1023, 10.1056/NEJM198010303031802

Harrell, 1985, Healing of bone disease in x-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol, J Clin Invest, 75, 1858, 10.1172/JCI111900

Chesney, 1983, Long-term influence of calcitriol (1,25-dihydroxyvitamin d) and supplemental phosphate in x-linked hypophosphatemic rickets, Pediatrics, 71, 559, 10.1542/peds.71.4.559